JY
MBOT icon

Jeff Yass’s Microbot Medical MBOT Stock Holding History

Jeff Yass’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Sell
525,827
-398,480
-43% -$812K ﹤0.01% 8134
2026
Q1 		$2.23M Sell
924,307
-320,816
-26% -$717K ﹤0.01% 5926
2025
Q4 		$2.49M Sell
1,245,123
-4,902
-0.4% -$11.6K ﹤0.01% 5205
2025
Q3 		$3.81M Buy
1,250,025
+1,218,186
+3,826% +$3.8M ﹤0.01% 4551
2025
Q2 		$80.2K Sell
31,839
-72,341
-69% -$173K ﹤0.01% 11906
2025
Q1 		$157K Buy
104,180
+74,452
+250% +$132K ﹤0.01% 11187
2024
Q4 		$33.3K Buy
+29,728
New +$29.1K ﹤0.01% 11816
2024
Q3 		– Sell
-10,404
Closed -$10.6K – 12591
2024
Q2 		$10.6K Buy
+10,404
New +$10.7K ﹤0.01% 11768
2016
Q3 		– Sell
-153
Closed -$8K – 8777
2016
Q2 		$8K Buy
+153
New +$44.1K ﹤0.01% 8430
2015
Q4 		– Sell
-12
Closed -$8K – 9728
2015
Q3 		$8K Buy
+12
New +$9.12K ﹤0.01% 9550
2014
Q4 		– Sell
-990
Closed -$2.02M – 9897
2014
Q3 		$2.02M Buy
+990
New +$2.61M ﹤0.01% 4603

Other funds holding MBOT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jeff Yass's MBOT Position: Q2 2026 in Review

Jeff Yass reduced its Microbot Medical (MBOT) stake by 43% in Q2 2026, selling an estimated $812K and leaving 525,827 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #8134.

Jeff Yass first reported a position in MBOT in Q3 2014 and has held it in 11 quarters since. The position peaked at $3.81M in Q3 2025. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Jeff Yass held 525,827 shares of Microbot Medical worth $1.03M as of Q2 2026.
  • Jeff Yass sold 398,480 Microbot Medical shares in Q2 2026, an estimated $812K.
  • Microbot Medical made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #8134 holding.
  • Jeff Yass first reported a position in Microbot Medical in Q3 2014 and has held it in 11 quarters since.
  • Jeff Yass's Microbot Medical position peaked at $3.81M in Q3 2025.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.